| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Insulin Resistance | |||||
| Postmenopause | |||||
| 2 | More general conditions related to this trial | ||||
| Glucose Metabolism Disorders | |||||
| Hyperinsulinism | |||||
| Metabolic Diseases | |||||
| 3 | Interventions listed in this trial | ||||
| metformin | |||||
| leuprolide acetate | |||||
| placebo pill | |||||
| placebo injection | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Leuprolide | |||||
| Testosterone | |||||
| 5 | More general drug interventions related to this trial | ||||
| Androgens | |||||
| Antineoplastic Agents | |||||
| Antineoplastic Agents, Hormonal | |||||
| Fertility Agents | |||||
| Fertility Agents, Female | |||||
| Hormones | |||||
| Hormones, Hormone Substitutes, and Hormone Antagonists | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Reproductive Control Agents | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| National Institute on Aging (NIA) | |||||
| The John A. Hartford Foundation | |||||
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | |||||
| University of Pennsylvania Diabetes and Endocrinology Research Center (DERC) | |||||
| TAP Pharmaceutical Products Inc. | |||||
|
